Study to Assess Platelet Dysfunction With Verify Now Assay
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 2/8/2019 |
| Start Date: | December 2009 |
| End Date: | February 2012 |
"In-vitro Characterization of Platelet Dysfunction in Common Hematological Disorders Using the Verify Now Assay"
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation
defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP)
and myeloproliferative disorders (MPD).
defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP)
and myeloproliferative disorders (MPD).
Verify Now is a rapid, simple, point-of service assay to measure platelet aggregation. The
verify now assay is designed to assess platelet function based on the ability of activated
platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet
functional abnormalities in patients with hematological disorders.
verify now assay is designed to assess platelet function based on the ability of activated
platelets to bind fibrinogen. It is hoped that this study will detect the subtle platelet
functional abnormalities in patients with hematological disorders.
Inclusion Criteria
- Patients with common blood disorders such as immune thrombocytopenia purpura(ITP)
myelodysplastic syndrome MDS)and myeloproliferative disorders (MPV)
Exclusion Criteria
- Patients with normal platelet counts
We found this trial at
1
site
Click here to add this to my saved trials
